The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma

Background: Skin cutaneous melanoma (SKCM) is one of the most common cutaneous malignancies, which incidence is increasing. Cuproptosis is a new type of programming cell death recently reported, which may affect the progression of SKCM.Method: The mRNA expression data of melanoma were obtained from...

Full description

Bibliographic Details
Main Authors:	Yuming Sun, Shaorong Lei, Xiangyue Luo, Chufeng Jiang, Zhexuan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Pharmacology
Subjects:	cuproptosis prognostic model skin cutaneous melanoma bioinformatics tumor mutational burden (TMB)
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1129544/full

Similar Items

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
by: Xiaojing Yang, et al.
Published: (2022-09-01)

Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
by: Da Liu, et al.
Published: (2023-01-01)

The role of cuproptosis-related gene in the classification and prognosis of melanoma
by: Jin-Ya Liu, et al.
Published: (2022-10-01)

High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
by: Shixin Zhao, et al.
Published: (2022-05-01)

Role of hippo pathway and cuproptosis-related genes in immune infiltration and prognosis of skin cutaneous melanoma
by: Haozhen Lv, et al.
Published: (2024-03-01)

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
by: Dong Hou, et al.
Published: (2022-08-01)

Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma
by: Qirui Wang, et al.
Published: (2023-01-01)

A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma
by: Yi Zhou, et al.
Published: (2022-07-01)

Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
by: Hanwen Wang, et al.
Published: (2021-12-01)

Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status
by: Xiaoying Cao, et al.
Published: (2023-01-01)

Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with skin cutaneous melanoma
by: Xin Shen, et al.
Published: (2023-01-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
by: Zhixun Bai, et al.
Published: (2022-12-01)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
by: Mingyu Li, et al.
Published: (2023-02-01)

Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
by: Yang Li, et al.
Published: (2021-07-01)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
by: Junya Yan, et al.
Published: (2020-11-01)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
by: Jia Li, et al.
Published: (2022-09-01)

FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma
by: Zhenguo Cai, et al.
Published: (2023-11-01)

Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis
by: Chao Mei, et al.
Published: (2020-10-01)

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma
by: Yalin Xie, et al.
Published: (2022-02-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden
by: George Georgoulias, et al.
Published: (2022-10-01)

Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma
by: Xie R, et al.
Published: (2020-12-01)

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma
by: Liping Liang, et al.
Published: (2022-07-01)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
by: Jiahua Xing, et al.
Published: (2022-07-01)

Identification of Potential Biomarkers and Small Molecule Drugs for Cutaneous Melanoma Using Integrated Bioinformatic Analysis
by: Yong Liu, et al.
Published: (2022-03-01)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
by: Zheng Zhou, et al.
Published: (2022-12-01)

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
by: Hongjin Wang, et al.
Published: (2023-07-01)

Bioinformatic-based genetic characterizations of neural regulation in skin cutaneous melanoma
by: Fengdi Wang, et al.
Published: (2023-06-01)

m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
by: Suyang Huang, et al.
Published: (2021-05-01)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
by: Mengyang Zhang, et al.
Published: (2023-03-01)

A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma
by: Jia He, et al.
Published: (2023-01-01)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Liuqing Yang, et al.
Published: (2022-07-01)

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
by: Weichen Wang, et al.
Published: (2022-08-01)

Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma
by: Haoxuan Ying, et al.
Published: (2021-05-01)

Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma
by: Wentao Lin, et al.
Published: (2024-02-01)

Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients
by: Tao Lu, et al.
Published: (2019-10-01)

Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis
by: Guoliang Jia, et al.
Published: (2021-04-01)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
by: Xueying Zhao, et al.
Published: (2022-10-01)

Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer
by: Yaoyu Zhang, et al.
Published: (2022-09-01)

System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma
by: Shixin Zhao, et al.
Published: (2023-11-01)